ERT

    OverviewSuggest Edit

    ERT is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions in centralized Cardiac Safety, Respiratory, Suicide Risk Assessment, electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products. 

    TypePrivate
    Founded1972
    HQPhiladelphia, US
    Websiteert.com
    Employee Ratings2.6
    Culture scoreD

    Latest Updates

    Employees (est.) (Dec 2019)3,780
    Job Openings93

    Key People/Management at ERT

    James Corrigan

    James Corrigan

    President and CEO
    Waqar Nasim

    Waqar Nasim

    EVP, Chief Financial Officer
    Steve Nuckols

    Steve Nuckols

    EVP, Chief Commercial Officer
    Andrea Valente

    Andrea Valente

    EVP, Chief Development Officer
    David Elario

    David Elario

    EVP, Operations Delivery
    Achim Schulke

    Achim Schulke

    EVP, Respiratory Solutions
    Show more

    ERT Office Locations

    ERT has offices in Philadelphia, Boston, Bridgewater, Bristol and in 14 other locations
    Philadelphia, US (HQ)
    1818 Market Street, 1818 Market St
    Boston, US
    500 Rutherford Ave
    Bridgewater, US
    685 US-202
    Bridgewater, US
    685 US-206
    Bristol, US
    1501 Grundy Ln Suite A
    Cleveland, US
    1111 Superior Ave
    Show all (19)

    ERT Financials and Metrics

    Summary Metrics

    Founding Date

    1972

    ERT Acquisitions / Subsidiaries

    Company NameDateDeal Size
    iCardiac TechnologiesDecember 04, 2017

    ERT Online and Social Media Presence

    Embed Graph

    ERT Company Culture

    • Overall Culture

      D

      57/100

    • CEO Rating

      F

      50/100

    • Compensation

      C-

      61/100

    Learn more on Comparably

    ERT News and Updates

    E-Clinical Solution Software Market Size, Status and Forecast 2019-2025: Oracle, Merge Healthcare, Medidata Solutions, PAREXEL International, BioClinica, ERT

    The qualitative research study conducted by HTF MI titled “Global E-Clinical Solution Software Market Size, Status and Forecast 2019-2025” provides primary Data, surveys, Scope of the Product and vendor briefings. Posted via Industry Today. Follow us on Twitter @IndustryToday

    Global Clinical Trial Imaging Market Growth, Development and Key Manufacturer Analysis Report 2019-2025 PAREXEL International Corporation, ICON plc, IXICO plc, Intrinsic Imaging, LLC, ERT Clinical, BioTelemetry, Inc., Cardiovascular Imaging Technologies,

    This report provides an in-depth insight of global Clinical Trial Imaging industry covering all necessary parameters together with development trends, challenges, opportunities, key manufacturers and competitive analysis. Posted via Industry Today. Follow us on Twitter @IndustryToday

    Cognitive Assessment Global Market 2018-2025: Cambridge Cognition, Cognifit, Cogstate, ERT Clinical, Groupe SBT

    Wiseguyreports.Com Publish New Market Research Report On -“Cognitive Assessment Market - Global Industry Analysis, Size, Share, Trends, Growth and Forecast 2018 - 2025” Posted via Industry Today. Follow us on Twitter @IndustryToday

    LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Nielsen Holdings PLC To Contact The Firm

    NEW YORK, Aug. 16, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Nielsen Holdings PLC ("Nielsen" or the "Company") (NYSE:NLSN) of the October 9, 2018 deadline to seek the role of lead plaintiff in a federal securities class action...

    LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Rockwell Medical, Inc. To Contact The Firm

    NEW YORK, Aug. 16, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Rockwell Medical, Inc. ("Rockwell" or the "Company") (NASDAQ: RMTI) of the September 25, 2018 deadline to seek the role of lead plaintiff in a federal securities...

    SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Eyenovia, Inc. (EYEN)

    NEW YORK, Aug. 16, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Eyenovia, Inc. ("Eyenovia" or the "Company") (NASDAQ: EYEN). Such investors are encouraged to obtain additional information and...
    Show more

    ERT Blogs

    Marcus Evans Evolution Summit USA

    Join Brion Regan, ERT’s Director, Product Management, Trial Oversight, as he presents “Saving Time & Money Through More Proactive Trial Management” at the Marcus Evans Evolution Summit USA in September. The post Marcus Evans Evolution Summit USA appeared first on ERT.

    Four Steps to Implementing Risk-based Quality Management

    Learn how a Risk-based Quality Management (RBQM) approach to trial management ─ including technology that integrates data from multiple sources for real-time decision making ─ helps sponsors and CROs mitigate clinical trial risks before they become costly problems. The post Four Steps to Implementin…

    SCDM 2018

    Join Nick Neri, ERT’s Director of Data Integration & Services, for “Single Source of Truth, Integrations or IoT (Internet of Things): Exploring Ways to Improve Connectedness of Clinical Data” at 3:30 on September 25. The post SCDM 2018 appeared first on ERT.

    ERS International Congress 2018

    Visit ERT representatives at stand C-11A at the European Respiratory Society (ERS) International Congress 2018 to see how ERT can help you optimize pulmonary function data quality for better patient and site performance, increase protocol compliance and reduce investigative site burden. The post ERS…

    Navigating the Response Assessment Criteria for Lymphoma

    Learn how recent changes to the standard treatment response criteria used in lymphoma clinical trials ─ including new biomarkers and different imaging methods ─ are enabling more accurate and effective patient assessment and management. The post Navigating the Response Assessment Criteria for Lympho…

    Outsourcing in Clinical Trials – Midwest

    Join Jenny Lohan, ERT’s product manager for Trial Oversight, as she presents “Beyond Risk-based Monitoring: Employing Risk-based Management” at Outsourcing in Clinical Trials—Midwest in September. The post Outsourcing in Clinical Trials – Midwest appeared first on ERT.
    Show more

    ERT Frequently Asked Questions

    • When was ERT founded?

      ERT was founded in 1972.

    • Who are ERT key executives?

      ERT's key executives are James Corrigan, Waqar Nasim and Steve Nuckols.

    • How many employees does ERT have?

      ERT has 3,780 employees.

    • Who are ERT competitors?

      Competitors of ERT include Veterans Evaluation Services, Truesdail Laboratories and Oxford Immunotec.

    • Where is ERT headquarters?

      ERT headquarters is located at 1818 Market Street, 1818 Market St, Philadelphia.

    • Where are ERT offices?

      ERT has offices in Philadelphia, Boston, Bridgewater, Bristol and in 14 other locations.

    • How many offices does ERT have?

      ERT has 19 offices.